Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Real time visualisation of radiofrequency ablation

A team of USC Viterbi School of Engineering researchers are making it easier, faster and safer for doctors to use an emerging procedure - one that involves burning away tumours in more patients, including those with brain tumours : Radiofrequency ablation, or RFA, is a minimally invasive procedure that uses electrical energy to destroy cancer cells with heat.

A needle-thin probe delivers radiofrequency waves directly to the tumour, cooking the tissue up to 140 degrees Fahrenheit, (60 degrees Celsius), until it's destroyed.

"Although ablation is becoming increasingly popular, there is still no thermal imaging technology in regular clinical use to monitor these procedures in real time and ensure that the correct thermal dose is delivered the first time," said research assistant professor John Stang of the Ming Hsieh Department of Electrical Engineering, who co-authored the study published in IEEE Transactions on Biomedical Engineering.

Together with Mahta Moghaddam, director of the Microwave Systems, Sensors, and Imaging Lab, or MiXIL, and holder of the William M. Hogue Professorship in Electrical Engineering at USC, Stang has developed a real-time thermal imaging method and device that will help doctors deliver fast, safe and precise thermal ablation treatments for a variety of ailments ranging from tumours to epilepsy.

Surgeons and interventional radiologists rely on the guidance provided by ultrasound, CT, or MRI to perform these life-saving operations. But since there is no real-time monitoring, a follow-up imaging study is needed to confirm proper treatment.

This extends time in the operating room, increases risks and costs, Moghaddam explained.

"Without real-time monitoring, there is the potential for both under-treatment and over-treatment," she said. "If there is under-treatment, doctors must perform additional rounds of thermal ablation until all of the tumours is destroyed. Each repeat ablation carries increased risk of infection or other complications and takes up more time in the operating room."

In the case of over-treatment, there is a risk of collateral damage to the surrounding healthy tissue.

This can be especially dangerous when the tumour is located close to sensitive structures, near a blood vessel or deep in the skull.

"With our technology, however, we can guide the treatment and focus on a very specific area," Stang said. "A microwave antenna array is placed around the region to be treated, with room left open for the surgeon to insert an ablation probe."

During the procedure, microwave signals are continuously transmitted and received into the treatment area.

From these signals and information from a prior imaging study, like an MRI, Moghaddam and Stang produce a 3D thermal image of the region in real-time, giving doctors a quantitative temperature map of the region they're operating on.

"In in vitro experimental validation studies, our system was able to achieve one-degree Celsius accuracy at a refresh rate of one frame per second," Stang said.

One issue they have to contend with is the resolution of their thermal image is not as high as that of MRI.

But Stang sees a world in which this real-time thermal image feed can be overlaid on a high-resolution MRI enabling doctors to precisely deliver the right dose to the right location, without the need for follow-up imaging studies.

For the next phase, their procedure will undergo animal testing later this year, specifically looking at liver cancer with support from the USC Alfred E. Mann Institute for Biomedical Engineering and in collaboration with the USC Keck School of Medicine.

Source: University of Southern California

0

Comments

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation